Yuexin Health announced that revenue for the first half of 2026 was 509 million yuan, an increase of 4.23% over the previous year. Net profit attributable to shareholders of listed companies was 5.331 million yuan, and net profit for the same period last year was 1,768 million yuan, an increase of 201.54% over the previous year. After deducting non-net profit of 844,400 yuan, a loss of 15.5561 million yuan for the same period last year. The company plans not to pay cash dividends, bonus shares, and not to use the Provident Fund to increase share capital.

Yuexin Health announced that revenue for the first half of 2026 was 509 million yuan, an increase of 4.23% over the previous year. Net profit attributable to shareholders of listed companies was 5.331 million yuan, and net profit for the same period last year was 1,768 million yuan, an increase of 201.54% over the previous year. After deducting non-net profit of 844,400 yuan, a loss of 15.5561 million yuan for the same period last year. The company plans not to pay cash dividends, bonus shares, and not to use the Provident Fund to increase share capital.